Literature DB >> 27567698

Prenatal cannabis exposure - The "first hit" to the endocannabinoid system.

Kimberlei A Richardson1, Allison K Hester2, Gabrielle L McLemore3.   

Abstract

As more states and countries legalize medical and/or adult recreational marijuana use, the incidences of prenatal cannabis exposure (PCE) will likely increase. While young people increasingly view marijuana as innocuous, marijuana preparations have been growing in potency in recent years, potentially creating global clinical, public health, and workforce concerns. Unlike fetal alcohol spectrum disorder, there is no phenotypic syndrome associated with PCE. There is also no preponderance of evidence that PCE causes lifelong cognitive, behavioral, or functional abnormalities, and/or susceptibility to subsequent addiction. However, there is compelling circumstantial evidence, based on the principles of teratology and fetal malprogramming, suggesting that pregnant women should refrain from smoking marijuana. The usage of marijuana during pregnancy perturbs the fetal endogenous cannabinoid signaling system (ECSS), which is present and active from the early embryonic stage, modulating neurodevelopment and continuing this role into adulthood. The ECSS is present in virtually every brain structure and organ system, and there is also evidence that this system is important in the regulation of cardiovascular processes. Endocannabinoids (eCBs) undergird a broad spectrum of processes, including the early stages of fetal neurodevelopment and uterine implantation. Delta-9-tetrahydrocannabinol (THC), the psychoactive chemical in cannabis, enters maternal circulation, and readily crosses the placental membrane. THC binds to CB receptors of the fetal ECSS, altering neurodevelopment and possibly rewiring ECSS circuitry. In this review, we discuss the Double-Hit Hypothesis as it relates to PCE. We contend that PCE, similar to a neurodevelopmental teratogen, delivers the first hit to the ECSS, which is compromised in such a way that a second hit (i.e., postnatal stressors) will precipitate the emergence of a specific phenotype. In summary, we conclude that perturbations of the intrauterine milieu via the introduction of exogenous CBs alter the fetal ECSS, predisposing the offspring to abnormalities in cognition and altered emotionality. Based on recent experimental evidence that we will review here, we argue that young women who become pregnant should immediately take a "pregnant pause" from using marijuana.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Double hit hypothesis; Epigenetics; Fetal malprogramming; Fetal neurodevelopment; Marijuana; Maternal cannabis exposure; Neurodevelopment; Prenatal cannabis exposure

Mesh:

Substances:

Year:  2016        PMID: 27567698     DOI: 10.1016/j.ntt.2016.08.003

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  29 in total

1.  Prenatal tobacco and marijuana co-use: Impact on newborn neurobehavior.

Authors:  Laura R Stroud; George D Papandonatos; Meaghan McCallum; Tessa Kehoe; Amy L Salisbury; Marilyn A Huestis
Journal:  Neurotoxicol Teratol       Date:  2018-09-26       Impact factor: 3.763

Review 2.  Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders.

Authors:  Nora L Nock; Sonia Minnes; Jay L Alberts
Journal:  Birth Defects Res       Date:  2017-12-01       Impact factor: 2.344

3.  Prenatal THC exposure raises kynurenic acid levels in the prefrontal cortex of adult rats.

Authors:  Sarah Beggiato; Alessandro Ieraci; Maria Cristina Tomasini; Robert Schwarcz; Luca Ferraro
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-02-04       Impact factor: 5.067

Review 4. 

Authors:  Sophia Badowski; Graeme Smith
Journal:  Can Fam Physician       Date:  2020-02       Impact factor: 3.275

Review 5.  Consequences of Perinatal Cannabis Exposure.

Authors:  Andrew F Scheyer; Miriam Melis; Viviana Trezza; Olivier J J Manzoni
Journal:  Trends Neurosci       Date:  2019-10-08       Impact factor: 13.837

6.  Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes.

Authors:  Daniel J Corsi; Laura Walsh; Deborah Weiss; Helen Hsu; Darine El-Chaar; Steven Hawken; Deshayne B Fell; Mark Walker
Journal:  JAMA       Date:  2019-07-09       Impact factor: 56.272

7.  Prenatal tobacco and marijuana co-use: Sex-specific influences on infant cortisol stress response.

Authors:  Laura R Stroud; George D Papandonatos; Nancy C Jao; Chrystal Vergara-Lopez; Marilyn A Huestis; Amy L Salisbury
Journal:  Neurotoxicol Teratol       Date:  2020-04-11       Impact factor: 3.763

Review 8.  Cannabis use during pregnancy and postpartum.

Authors:  Sophia Badowski; Graeme Smith
Journal:  Can Fam Physician       Date:  2020-02       Impact factor: 3.275

9.  Sex-specific behavioural deficits induced at early life by prenatal exposure to the cannabinoid receptor agonist WIN55, 212-2 depend on mGlu5 receptor signalling.

Authors:  Antonia Manduca; Michela Servadio; Francesca Melancia; Sara Schiavi; Olivier J Manzoni; Viviana Trezza
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

10.  Cannabinoid Exposure via Lactation in Rats Disrupts Perinatal Programming of the Gamma-Aminobutyric Acid Trajectory and Select Early-Life Behaviors.

Authors:  Andrew F Scheyer; Milene Borsoi; Jim Wager-Miller; Anne-Laure Pelissier-Alicot; Michelle N Murphy; Ken Mackie; Olivier J J Manzoni
Journal:  Biol Psychiatry       Date:  2019-09-05       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.